| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Revenue | $5.14B | +3.6% |
| Cost of Revenue | $2.92B | +4.4% |
| Gross Profit | $2.22B | +2.7% |
| R&D Expense | $103.7M | +2.1% |
| SG&A Expense | $1.25B | -3.6% |
| Operating Income | $836.1M | +211.8% |
| Interest Expense | $144.4M | +33.7% |
| Pre-tax Income | $702.8M | +346.7% |
| Income Tax | $149.5M |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $1.01B | +8.6% |
| Inventory | $674.5M | -3.0% |
| Current Assets | $2.87B | +42.6% |
| Total Assets | $11.06B | +2.2% |
| Current Liabilities | $931.1M | +8.0% |
| Long-term Debt | $3.12B | +3.4% |
| Total Liabilities | $4.75B | +0.3% |
| Line Item | 2024-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $973.3M | +28.6% |
| Capital Expenditures | $360.3M | -0.5% |
| Investing Cash Flow | -$887.4M | -131.5% |
| Financing Cash Flow | -$85.2M | +82.9% |
| Free Cash Flow | $612.9M | +55.2% |
| +190.2% |
| Net Income | $378.2M | +253.4% |
| EPS (Basic) | $3.83 | +257.9% |
| EPS (Diluted) | $3.81 | +256.1% |
| Stockholders' Equity |
| $6.30B |
| +3.7% |